v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities:    
Net income $ 15,100,000 $ 44,500,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 20,000,000.0 20,900,000
Amortization of debt discounts and issuance costs 500,000 700,000
Amortization of deferred commissions costs 17,400,000 18,800,000
Loss on debt modification and extinguishment 0 2,200,000
Equity-based compensation expense 31,200,000 37,700,000
Deferred income taxes 13,200,000 27,900,000
Tax receivable agreement remeasurement 9,600,000 (10,100,000)
Provision for bad debt expense 9,200,000 6,100,000
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net 39,300,000 1,300,000
Prepaid expenses and other current assets (11,900,000) (9,900,000)
Deferred costs and other assets, net of current portion (17,600,000) (16,400,000)
Income tax receivable (1,200,000) (2,300,000)
Accounts payable (16,900,000) (10,300,000)
Accrued expenses and other liabilities 5,500,000 (34,000,000.0)
Unearned revenue 2,500,000 31,500,000
Net cash provided by operating activities 115,900,000 108,600,000
Investing activities:    
Purchases of short-term investments 0 (63,600,000)
Maturities of short-term investments 48,200,000 50,400,000
Purchases of property and equipment and other assets (12,800,000) (6,400,000)
Net cash provided by (used in) investing activities 35,400,000 (19,600,000)
Financing activities:    
Payments of deferred consideration (700,000) 0
Repayment of debt (1,500,000) (1,500,000)
Payments of debt issuance and modification costs (800,000) (2,000,000.0)
Proceeds from exercise of stock options 0 200,000
Taxes paid related to net share settlement of equity awards (7,100,000) (4,100,000)
Tax receivable agreement payments (31,600,000) 0
Repurchase of common stock (151,000,000.0) (21,900,000)
Net cash used in financing activities (192,700,000) (29,300,000)
Net increase (decrease) in cash, cash equivalents, and restricted cash (41,400,000) 59,700,000
Cash, cash equivalents, and restricted cash at beginning of period 456,200,000 424,100,000
Cash, cash equivalents, and restricted cash at end of period 414,800,000 483,800,000
Cash, cash equivalents, and restricted cash at end of period:    
Cash and cash equivalents 405,900,000 474,000,000.0
Restricted cash, non-current 8,900,000 9,800,000
Total cash, cash equivalents, and restricted cash 414,800,000 483,800,000
Supplemental disclosures of cash flow information    
Interest paid in cash 17,700,000 18,700,000
Cash paid for taxes 3,300,000 1,700,000
Supplemental disclosures of non-cash investing and financing activities:    
Property and equipment included in accounts payable and accrued expenses and other current liabilities 2,100,000 800,000
Equity-based compensation included in capitalized software $ 1,500,000 $ 0